Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors
- Name
- Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors
- Accession Number
- DBCAT001767
- Description
Not Available
- Drugs
Drug Drug Description Talabostat Investigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), lung cancer, melanoma, and pancreatic cancer. AB192 Investigated for use/treatment in diabetes mellitus type 2. - Drugs & Drug Targets
Drug Target Type AB192 Myeloperoxidase enzyme